Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class.
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class.
复制标题
DOI:
10.1016/j.celrep.2021.108950
复制
发表时间:
2021-04-06
期刊:
影响因子:
8.8
通讯作者:
Sheng Z
中科院分区:
文献类型:
--
作者:
Rapp M;Guo Y;Reddem ER;Yu J;Liu L;Wang P;Cerutti G;Katsamba P;Bimela JS;Bahna FA;Mannepalli SM;Zhang B;Kwong PD;Huang Y;Ho DD;Shapiro L;Sheng Z
Antibodies with heavy chains that derive from the VH1-2 gene constitute some of the most potent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing antibodies yet identified. To provide insight into whether these genetic similarities inform common modes of recognition, we determine the structures of the SARS-CoV-2 spike in complex with three VH1-2-derived antibodies: 2-15, 2-43, and H4. All three use VH1-2-encoded motifs to recognize the receptor-binding domain (RBD), with heavy-chain N53I-enhancing binding and light-chain tyrosines recognizing F486RBD. Despite these similarities, class members bind both RBD-up and -down conformations of the spike, with a subset of antibodies using elongated CDRH3s to recognize glycan N343 on a neighboring RBD—a quaternary interaction accommodated by an increase in RBD separation of up to 12 Å. The VH1-2 antibody class, thus, uses modular recognition encoded by modular genetic elements to effect potent neutralization, with the VH-gene component specifying recognition of RBD and the CDRH3 component specifying quaternary interactions. Rapp et al. determine structures of three human VH1-2-derived SARS-CoV-2-neutralizing antibodies and define a prevalent multi-donor antibody class that recognizes the receptor-binding domain (RBD) with convergent heavy- and light-chain modules. They further show the structural basis for RBD-up and RBD-down recognition and quaternary recognition-mediated spike-conformation change.
登录
查看更多内容
DOI:
10.1126/science.abg3055
发表时间:
2021-04-09
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Davies NG;Abbott S;Barnard RC;Jarvis CI;Kucharski AJ;Munday JD;Pearson CAB;Russell TW;Tully DC;Washburne AD;Wenseleers T;Gimma A;Waites W;Wong KLM;van Zandvoort K;Silverman JD;CMMID COVID-19 Working Group;COVID-19 Genomics UK (COG-UK) Consortium;Diaz-Ordaz K;Keogh R;Eggo RM;Funk S;Jit M;Atkins KE;Edmunds WJ
通讯作者:
Edmunds WJ
影响因子:
64.8
作者:
Barnes CO;Jette CA;Abernathy ME;Dam KA;Esswein SR;Gristick HB;Malyutin AG;Sharaf NG;Huey-Tubman KE;Lee YE;Robbiani DF;Nussenzweig MC;West AP Jr;Bjorkman PJ
通讯作者:
Bjorkman PJ
影响因子:
48
作者:
Barad BA;Echols N;Wang RY;Cheng Y;DiMaio F;Adams PD;Fraser JS
通讯作者:
Fraser JS
DOI:
10.1107/s0907444905036693
发表时间:
2006-01-01
影响因子:
2.2
作者:
Evans, P
通讯作者:
Evans, P
影响因子:
46.9
作者:
通讯作者:
--